ASAS/EULAR recommendations for the management of ankylosing spondylitis

By J. Zochling, D. Heijde, R. Burgos-Vargas, E. Collantes, John C. Davis, B. Dijkmans, M. Dougados, P. Géher, R. Inman, M. Khan and 12 more. Annals of the Rheumatic Diseases, 2005

781 citations recorded by the source corpus.

Subfields: Pathology and Forensic Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/fbff40763e399c85fb042bfe1892e37e2dc668bf

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Gottlieb
2. C. Ritchlin
3. A. Kavanaugh
4. D. Heijde
5. P. Mease
6. Jürgen Braun
7. D. Gladman
8. J. Sieper

Citations in the corpus

• 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis (2011, background): “20 – 23 AS is the prototype, 24 a subtype, and an outcome of spondyloarthritis, particularly of the axial form of spondyloarthritis.”
• Treatment recommendations for psoriatic arthritis (2008, methodology): “for treatment recommendations based on evidence derived in AS. Traditional oral DMARDs such as methotrexate, leflunomide and sulfasalazine, have not been shown to be effective in axial manifestations of AS”